Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 11, Pages 5606
Publisher
MDPI AG
Online
2021-05-26
DOI
10.3390/ijms22115606
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
- (2021) Dongdong Zhang et al. Journal of Neuroinflammation
- The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
- (2021) Ludwig Aigner et al. Frontiers in Molecular Biosciences
- Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder
- (2021) Kristine Farmen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
- (2020) Ruwani S. Wijeyekoon et al. BRAIN BEHAVIOR AND IMMUNITY
- The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies
- (2020) Julia Marschallinger et al. Neurotherapeutics
- 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer’s disease
- (2020) Fang Chen et al. BRAIN BEHAVIOR AND IMMUNITY
- Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease
- (2020) Etienne C. Hirsch et al. MOVEMENT DISORDERS
- α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
- (2020) Cecilia S. Lindestam Arlehamn et al. Nature Communications
- Mystery Solved: Why Smoke Extract Worsens Disease in Smokers with Crohn’s Disease and Not Ulcerative Colitis? Gut MAP!
- (2020) Dania AlQasrawi et al. Microorganisms
- A possible effect of montelukast on neurological aging examined by the use of register data
- (2020) Bjørn Grinde et al. International Journal of Clinical Pharmacy
- Genetic and Environmental Factors in P arkinson's Disease Converge on Immune Function and Inflammation
- (2020) Elizabeth M. Kline et al. MOVEMENT DISORDERS
- Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention
- (2019) Yujeong Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease
- (2019) Laura Best et al. Current Neurology and Neuroscience Reports
- Corticobasal degeneration
- (2019) Per Svenningsson CURRENT OPINION IN NEUROLOGY
- Microglia responses to interleukin‐6 and type I interferons in neuroinflammatory disease
- (2019) Phillip K. West et al. GLIA
- Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
- (2019) Antonina Kouli et al. BRAIN BEHAVIOR AND IMMUNITY
- 5-Lipoxygenase as a drug target: A review on trends in inhibitors structural design, SAR and mechanism based approach
- (2019) Shweta Sinha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
- (2019) Banabihari Giri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
- (2019) Holly F. Green et al. Journal of Parkinsons Disease
- Asthma pharmacotherapy: an update on leukotriene treatments
- (2019) Hoang Kim Tu Trinh et al. Expert Review of Respiratory Medicine
- Zileuton ameliorates depressive-like behaviors, hippocampal neuroinflammation, apoptosis and synapse dysfunction in mice exposed to chronic mild stress
- (2019) Cai-Hong Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases
- (2019) Yuxi Wang et al. NEUROBIOLOGY OF AGING
- Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson’s Disease
- (2018) Annika Sommer et al. Cell Stem Cell
- An update on vinpocetine: New discoveries and clinical implications
- (2018) Yi-shuai Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inflammation in CNS neurodegenerative diseases
- (2018) Jodie Stephenson et al. IMMUNOLOGY
- Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer’s Disease Pathology
- (2018) Antonio Di Meco et al. JOURNAL OF ALZHEIMERS DISEASE
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Effect of montelukast in experimental model of Parkinson’s disease
- (2018) Vetrivel Babu Nagarajan et al. NEUROSCIENCE LETTERS
- Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
- (2018) Inga Peter et al. JAMA Neurology
- Immunosuppressants and risk of Parkinson disease
- (2018) Brad A. Racette et al. Annals of Clinical and Translational Neurology
- The leukotriene signaling pathway: a druggable target in Alzheimer’s disease
- (2018) Johanna Michael et al. DRUG DISCOVERY TODAY
- The role of T cells in the pathogenesis of Parkinson’s disease
- (2018) Zhichun Chen et al. PROGRESS IN NEUROBIOLOGY
- Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects
- (2018) Riham M. Mansour et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
- (2018) Xi Chen et al. Frontiers in Immunology
- TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model
- (2018) Michela Campolo et al. BRAIN BEHAVIOR AND IMMUNITY
- PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
- (2018) Katarina Varnäs et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease
- (2018) Syed Obaidur Rahman et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vinpocetine regulates levels of circulating TLRs in Parkinson’s disease patients
- (2018) Zhang Ping et al. NEUROLOGICAL SCIENCES
- Astrocyte Heterogeneity in the Adult Central Nervous System
- (2018) Sean J. Miller Frontiers in Cellular Neuroscience
- Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
- (2017) Chiara Cerami et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sifting through the surfeit of neuroinflammation tracers
- (2017) Paul Cumming et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
- (2017) Karamjeet Kaur et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
- (2017) Morten Gersel Stokholm et al. LANCET NEUROLOGY
- Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
- (2017) Paolo Gelosa et al. MEDIATORS OF INFLAMMATION
- Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson’s Disease
- (2017) Rosalba Siracusa et al. MOLECULAR NEUROBIOLOGY
- Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson’s disease
- (2017) Hannah Jang et al. NEUROREPORT
- Onset and progression factors in Parkinson’s disease: A systematic review
- (2017) Rosemary Martino et al. NEUROTOXICOLOGY
- The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
- (2017) Heather D.E. Booth et al. TRENDS IN NEUROSCIENCES
- Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients
- (2016) Morten Gersel Stokholm et al. ANNALS OF NEUROLOGY
- Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders
- (2016) Arijit Ghosh et al. CNS Neuroscience & Therapeutics
- Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines
- (2016) Qamre Alam et al. CURRENT PHARMACEUTICAL DESIGN
- Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies
- (2016) Maria Xilouri et al. MOVEMENT DISORDERS
- Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases
- (2016) Sarah A. Gagliano et al. Annals of Clinical and Translational Neurology
- Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease
- (2015) Aurelija Jucaite et al. BRAIN
- Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
- (2015) Sayinthen Vivekanantham et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Inflammation is genetically implicated in Parkinson’s disease
- (2015) N. Dzamko et al. NEUROSCIENCE
- Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug
- (2015) Julia Marschallinger et al. Nature Communications
- Blood Monocytes and Their Subsets: Established Features and Open Questions
- (2015) Loems Ziegler-Heitbrock Frontiers in Immunology
- Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1
- (2014) Xiao-Yan Zhang et al. BRAIN RESEARCH
- Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
- (2014) Magnus Bäck et al. BRITISH JOURNAL OF PHARMACOLOGY
- Montelukast rescues primary neurons against Aβ1–42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling
- (2014) Jin’e Lai et al. NEUROCHEMISTRY INTERNATIONAL
- Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
- (2014) Melissa E Murray et al. Alzheimers Research & Therapy
- Protection of dopaminergic neurons by 5-lipoxygenase inhibitor
- (2013) Kai-Hsiang Kang et al. NEUROPHARMACOLOGY
- Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
- (2012) Lisa Fellner et al. GLIA
- Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability
- (2012) V.P. Chou et al. NEUROSCIENCE
- Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
- (2011) Jesper Z. Haeggström et al. CHEMICAL REVIEWS
- Microglia and monocytes: 'tis plain the twain meet in the brain
- (2011) Richard M Ransohoff NATURE NEUROSCIENCE
- Cysteinyl leukotriene receptor 2 is spatiotemporally involved in neuron injury, astrocytosis and microgliosis after focal cerebral ischemia in rats
- (2011) C.Z. Zhao et al. NEUROSCIENCE
- Association of the human leucocyte antigen region with susceptibility to Parkinson's disease
- (2010) M. Saiki et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
- (2008) Vanessa Brochard et al. JOURNAL OF CLINICAL INVESTIGATION
- Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
- (2008) Linda B. Moran et al. NEUROGENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started